New: Introducing the Finviz Crypto Map

Learn More
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#175 / 200 Total
CAI - Caris Life Sciences Inc - Stock Price Chart
TickerCAI [NASD]
CompanyCaris Life Sciences Inc
CountryUSA
IndustryBiotechnology
Market Cap8.73BEPS (ttm)-10.43
P/E-EPS this Y19.50%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S19.29EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q49.90%
Insider Own48.50%Inst Own2.30%
Insider Trans0.03%Inst Trans49.80%
Short Float1.12%EarningsMay 28
Analyst Recom-Target Price-
Avg Volume1.85M52W Range25.40 - 30.70
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Spetzler David BaxleyPresidentJun 20 '25Option Exercise2.4475,000183,000558,668Jun 23 06:41 PM
Denton John RusselSee RemarksJun 20 '25Buy21.007,500157,500123,591Jun 23 06:34 PM
Brille Brian JSee RemarksJun 20 '25Buy21.0030,000630,000162,428Jun 23 06:30 PM
LTBR - Lightbridge Corp - Stock Price Chart
TickerLTBR [NASD, RUT]
CompanyLightbridge Corp
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap341.92MEPS (ttm)-0.85
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y25.98%
P/S-EPS next 5Y-
P/B5.46EPS Q/Q-16.79%
Dividend-Sales Q/Q-
Insider Own6.83%Inst Own29.06%
Insider Trans-13.16%Inst Trans135.15%
Short Float19.63%EarningsMay 12/b
Analyst Recom-Target Price10.50
Avg Volume1.80M52W Range2.24 - 17.70
Lightbridge Corp. engages in the development and commercialization of next generation nuclear fuel technology. It offers Lightbridge Fuel, a proprietary next generation nuclear fuel technology for current and future reactors. The company was founded on January 8, 1992 and is headquartered in Reston, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GOLDMAN LARRYCFOJun 10 '25Option Exercise10.8012,861138,899192,687Jun 11 04:05 PM
GOLDMAN LARRYCFOJun 09 '25Option Exercise10.803,42036,936204,663Jun 11 04:05 PM
GOLDMAN LARRYCFOJun 09 '25Sale15.6824,837389,431179,826Jun 11 04:05 PM
GOLDMAN LARRYCFOJun 10 '25Sale16.3012,861209,634179,826Jun 11 04:05 PM
GOLDMAN LARRYOfficerJun 09 '25Proposed Sale15.8137,698596,005Jun 09 04:26 PM
DNN - Denison Mines Corp - Stock Price Chart
TickerDNN [AMEX]
CompanyDenison Mines Corp
CountryCanada
IndustryUranium
Market Cap1.82BEPS (ttm)-0.09
P/E-EPS this Y-6.68%
Forward P/E-EPS next Y57.06%
PEG-EPS past 5Y-26.28%
P/S556.45EPS next 5Y37.17%
P/B5.01EPS Q/Q-105.45%
Dividend-Sales Q/Q55.33%
Insider Own1.25%Inst Own51.39%
Insider Trans0.00%Inst Trans2.81%
Short Float8.77%EarningsMay 13/b
Analyst Recom1.08Target Price2.78
Avg Volume110.36M52W Range1.08 - 2.47
Denison Mines Corp. engages in the exploration and development of uranium. The firm has interests in the Athabasca Basin, Wheeler River, Midwest Project, McClean Lake, and Waterbury Lake. The company was founded on May 9, 1997 and is headquartered in Toronto, Canada.
ENTX - Entera Bio Ltd - Stock Price Chart
TickerENTX [NASD]
CompanyEntera Bio Ltd
CountryIsrael
IndustryBiotechnology
Market Cap92.72MEPS (ttm)-0.26
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.19%
P/S421.47EPS next 5Y-
P/B4.78EPS Q/Q-7.83%
Dividend-Sales Q/Q-
Insider Own29.60%Inst Own22.49%
Insider Trans0.00%Inst Trans132.37%
Short Float0.17%EarningsMay 09/a
Analyst Recom1.00Target Price10.00
Avg Volume40.77K52W Range1.41 - 2.79
Jul-08-25 08:00AM OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress (GlobeNewswire)
Jun-26-25 08:00AM Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting (GlobeNewswire)
Jun-25-25 08:00AM OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting (GlobeNewswire)
May-09-25 04:05PM Entera Bio Announces First Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Apr-15-25 08:30AM Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO (GlobeNewswire)
Mar-28-25 04:05PM Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-18-25 11:37AM Opko and Entera focus on oral care for obesity and metabolic disorders (Pharmaceutical Technology)
Mar-17-25 08:00AM OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders (GlobeNewswire)
Feb-24-25 08:30AM Entera Bio to Participate in Upcoming Events (GlobeNewswire)
Feb-19-25 08:00AM EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (GlobeNewswire)
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LIEBERMAN GERALD MDirectorApr 01 '25Option Exercise1.0023,95223,952300,160Apr 03 04:06 PM
NA - Nano Labs Ltd - Stock Price Chart
TickerNA [NASD]
CompanyNano Labs Ltd
CountryChina
IndustrySemiconductors
Market Cap199.87MEPS (ttm)-2.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-41.32%
P/S35.44EPS next 5Y-
P/B4.20EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own68.44%Inst Own17.84%
Insider Trans0.00%Inst Trans2.49%
Short Float4.46%EarningsMar 25/b
Analyst Recom-Target Price-
Avg Volume570.85K52W Range2.75 - 31.48
Nano Labs Ltd. is a holding company, which engages in design and provision of product solution of fabless integrated circuit. It offers high throughput computing chips, high performance computing chips, distributed computing and storage solutions, smart network interface cards, vision computing chips, and distributed rendering. The company was founded in July 2019 and is headquartered in Hangzhou, China.
HSDT - Helius Medical Technologies Inc - Stock Price Chart
TickerHSDT [NASD]
CompanyHelius Medical Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap5.65MEPS (ttm)-2390.32
P/E-EPS this Y92.20%
Forward P/E-EPS next Y74.56%
PEG-EPS past 5Y63.29%
P/S13.14EPS next 5Y-
P/B0.05EPS Q/Q83.50%
Dividend-Sales Q/Q-63.70%
Insider Own25.71%Inst Own1.35%
Insider Trans0.00%Inst Trans-
Short Float1.65%EarningsMay 08
Analyst Recom1.00Target Price3000.00
Avg Volume149.74K52W Range7.15 - 1200.00
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
RITR - Reitar Logtech Holdings Ltd - Stock Price Chart
TickerRITR [NASD]
CompanyReitar Logtech Holdings Ltd
CountryHong Kong
IndustryEngineering & Construction
Market Cap321.16MEPS (ttm)0.08
P/E61.55EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S6.74EPS next 5Y-
P/B13.86EPS Q/Q509.76%
Dividend-Sales Q/Q164.44%
Insider Own77.81%Inst Own0.18%
Insider Trans0.00%Inst Trans75.93%
Short Float2.86%Earnings-
Analyst Recom-Target Price-
Avg Volume736.81K52W Range2.24 - 8.75
Reitar Logtech Holdings Ltd. is a holding company, which engages in the provision of construction management and engineering design services, asset management and investment, and professional consultancy services. It operates through Construction Management and Engineering Design Services and Asset Management and Professional Consultancy Services segments. The company was founded by Hau Lim Chung and Chun Yip Yiu in 2015 and is headquartered in Hong Kong.
XBIT - XBiotech Inc - Stock Price Chart
TickerXBIT [NASD]
CompanyXBiotech Inc
CountryUSA
IndustryBiotechnology
Market Cap90.85MEPS (ttm)-1.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.52EPS Q/Q-8.68%
Dividend-Sales Q/Q-
Insider Own36.04%Inst Own14.73%
Insider Trans0.00%Inst Trans-4.60%
Short Float2.74%Earnings-
Analyst Recom3.00Target Price28.00
Avg Volume95.18K52W Range2.50 - 8.32
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
ZKIN - ZK International Group Co Ltd - Stock Price Chart
TickerZKIN [NASD]
CompanyZK International Group Co Ltd
CountryChina
IndustrySteel
Market Cap14.77MEPS (ttm)-0.57
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.14EPS next 5Y-
P/B0.52EPS Q/Q96.62%
Dividend-Sales Q/Q-10.71%
Insider Own27.25%Inst Own0.41%
Insider Trans0.00%Inst Trans22.26%
Short Float1.31%Earnings-
Analyst Recom-Target Price-
Avg Volume2.51M52W Range0.82 - 6.30
May-21-25 08:30AM ZK International Launches Unique Financing Strategy as Public Market Gateway for Crypto's Viral Movement -- Targeting Billion Dollar XRP Community via ZKIN Warrants (PR Newswire) -20.34%
Feb-24-25 09:00AM ZK International Group Co., Ltd. Resolves Nasdaq Bid Price Deficiency and Remains in Compliance with Nasdaq Listing Standards (PR Newswire)
Feb-07-25 04:00PM ZK International Postpones Shareholder Call (PR Newswire) -16.67%
Jan-31-25 09:00AM ZK International's xSigma Corp. Plans to Launch xSigma Wallet: A Crypto Platform for Buying Memecoins & Digital Assets with Credit Cards (PR Newswire) +16.78%
Jan-29-25 09:00AM ZK International Group Announces 1-for-7 Reverse Stock Split (PR Newswire) -40.70%
Jan-28-25 08:00AM ZK International Group Co., Ltd. Announces Shareholder Call to Discuss Upcoming News and Strategic Growth Plans (PR Newswire) +20.40%
Jan-27-25 04:00PM ZK International Group Announces 405% Gross Profit Increase for the Fiscal Year 2024 (PR Newswire)
Nov-13-24 08:30AM ZK International Group Seeks to Accept Cryptocurrency Payments to Enhance Global Supplier, Vendor, and Customer Transactions (PR Newswire) +25.68%
Oct-03-24 07:45AM ZK International Group's Breakthrough Win in the Shenzhen Gas Project is Expected to Propel Growth Amid China's Economic Stimulus Which Should Exceed $284 Billion (PR Newswire) +10.99%
Sep-30-24 04:10PM ZK International Group Co., Ltd. Announces Record Revenue of $52.89 Million, an Increase of 6.5% for the First Half of Fiscal Year 2024 (PR Newswire) +14.42% +10.51%
ZK International Group Co., Ltd. is a holding company, which engages in the manufacture and sales of stainless steel band, copper strip, welded stainless steel pipes and fittings, valve, light industry machinery equipment, and other stainless steel products. The company was founded by Jian Cong Huang and Guo Lin Wang on May 13, 2015 and is headquartered in Wenzhou, China.
AHG - Akso Health Group ADR - Stock Price Chart
TickerAHG [NASD]
CompanyAkso Health Group ADR
CountryChina
IndustryMedical Distribution
Market Cap420.08MEPS (ttm)-0.06
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S49.66EPS next 5Y-
P/B2.09EPS Q/Q40.33%
Dividend-Sales Q/Q25.47%
Insider Own-Inst Own0.09%
Insider Trans-Inst Trans-8.24%
Short Float0.14%EarningsMar 28/b
Analyst Recom-Target Price4.00
Avg Volume35.10K52W Range0.74 - 2.35
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.
1101314151617181920